Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H20FN5O4 |
| Molecular Weight | 401.3916 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO\N=C1/CN(CC12CNC2)C3=NC4=C(C=C3F)C(=O)C(=CN4C5CC5)C(O)=O
InChI
InChIKey=ZNPOCLHDJCAZAH-OEAKJJBVSA-N
InChI=1S/C19H20FN5O4/c1-29-23-14-6-24(9-19(14)7-21-8-19)17-13(20)4-11-15(26)12(18(27)28)5-25(10-2-3-10)16(11)22-17/h4-5,10,21H,2-3,6-9H2,1H3,(H,27,28)/b23-14+
| Molecular Formula | C19H20FN5O4 |
| Molecular Weight | 401.3916 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Zabofloxacin (also known as DW-224a), a fluoroquinolone antibiotic agent, is a dual inhibitor of both DNA gyrase and topoisomerase IV of Streptococcus pneumonia. Zabofloxacin successfully has completed phase III clinical trial in patients with acute bacterial exacerbation of the chronic obstructive pulmonary disease. In addition, in May 2012, IASO terminated phase II trial of oral zabofloxacin capsules in patients with moderate-to-severe community-acquired pneumonia due to financial considerations.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| New treatment options for lower respiratory tract infections. | 2017-09 |
|
| DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae. | 2010-07 |
|
| Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains. | 2008-09 |
|
| Safety pharmacology of DW-224a, a novel fluoroquinolone antibiotic agent. | 2004-11 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01658020
Zabofloxacin 367mg tablet P.O. once daily for 5days and then Placebo P.O. once daily for 2days
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:30:21 GMT 2025
by
admin
on
Wed Apr 02 08:30:21 GMT 2025
|
| Record UNII |
LV66BA6V2G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C795
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
LV66BA6V2G
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
DB12479
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
C82232
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
Zabofloxacin
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
C480202
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
5249
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
8594
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
219680-11-2
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
100000182642
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
SUB196891
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107811
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
10388396
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY | |||
|
DTXSID10870251
Created by
admin on Wed Apr 02 08:30:21 GMT 2025 , Edited by admin on Wed Apr 02 08:30:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|